FDA Inspection 1199913 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on March 1, 2023 in Sumter, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 1, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Sumter, SC (United States)